1. Home
  2. LVWR vs TTRX Comparison

LVWR vs TTRX Comparison

Compare LVWR & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveWire Group Inc.

LVWR

LiveWire Group Inc.

HOLD

Current Price

$1.20

Market Cap

288.7M

Sector

N/A

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$9.57

Market Cap

281.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LVWR
TTRX
Founded
2022
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.7M
281.2M
IPO Year
2022
2025

Fundamental Metrics

Financial Performance
Metric
LVWR
TTRX
Price
$1.20
$9.57
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
10.4M
70.7K
Earning Date
05-05-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
19.57
N/A
EPS
N/A
N/A
Revenue
$25,672,000.00
N/A
Revenue This Year
$619.07
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.65
$2.57
52 Week High
$6.44
$11.69

Technical Indicators

Market Signals
Indicator
LVWR
TTRX
Relative Strength Index (RSI) 47.49 56.29
Support Level $1.11 $2.95
Resistance Level $1.66 $10.48
Average True Range (ATR) 0.39 0.85
MACD -0.06 0.02
Stochastic Oscillator 7.45 68.38

Price Performance

Historical Comparison
LVWR
TTRX

About LVWR LiveWire Group Inc.

LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. Electric Motorcycles segment sells electric motorcycles, related parts and accessories and apparel in the United States and certain international markets; STACYC segment sells electric balance bikes for kids, related parts and accessories and apparel in the United States and certain international markets. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel. Majority of revenue is from USA.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: